|
|
|
|
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response
|
|
|
|
|
|
|
|
نویسنده
|
pulloor n.k. ,nair s. ,kostic a.d. ,bist p. ,weaver j.d. ,riley a.m. ,tyagi r. ,uchil p.d. ,york j.d. ,snyder s.h. ,garcía-sastre a. ,potter b.v.l. ,lin r. ,shears s.b. ,xavier r.j. ,krishnan m.n.
|
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 2
|
|
چکیده
|
The pattern recognition receptor rig-i is critical for type-i interferon production. however,the global regulation of rig-i signaling is only partially understood. using a human genome-wide rnai-screen,we identified 226 novel regulatory proteins of rig-i mediated interferon-β production. furthermore,the screen identified a metabolic pathway that synthesizes the inositol pyrophosphate 1-ip7 as a previously unrecognized positive regulator of interferon production. detailed genetic and biochemical experiments demonstrated that the kinase activities of ippk,ppip5k1 and ppip5k2 (which convert ip5 to1-ip7) were critical for both interferon induction,and the control of cellular infection by sendai and influenza a viruses. conversely,ectopically expressed inositol pyrophosphate-hydrolases dipps attenuated interferon transcription. mechanistic experiments in intact cells revealed that the expression of ippk,ppip5k1 and ppip5k2 was needed for the phosphorylation and activation of irf3,a transcription factor for interferon. the addition of purified individual inositol pyrophosphates to a cell free reconstituted rig-i signaling assay further identified 1-ip7 as an essential component required for irf3 activation. the inositol pyrophosphate may act by β-phosphoryl transfer,since its action was not recapitulated by a synthetic phosphonoacetate analogue of 1-ip7. this study thus identified several novel regulators of rig-i,and a new role for inositol pyrophosphates in augmenting innate immune responses to viral infection that may have therapeutic applications.
|
|
|
|
|
آدرس
|
program on emerging infectious diseases,duke-nus graduate medical school, Singapore, program on emerging infectious diseases,duke-nus graduate medical school, Singapore, center for computational and integrative biology,massachusetts general hospital,harvard medical school,boston,ma, United States, program on emerging infectious diseases,duke-nus graduate medical school, Singapore, inositol signaling group,laboratory of signal transduction,national institute of environmental health sciences,nih,dhhs,research triangle park,nc, United States, department of pharmacy and pharmacology,university of bath,claverton down,bath, United Kingdom, solomon h. snyder department of neuroscience and departments of psychiatry and behavioral sciences,the johns hopkins university school of medicine,baltimore,md, United States, section of microbial pathogenesis,yale university school of medicine,new haven,ct, United States, department of biochemistry,vanderbilt university medical center,nashville,tn, United States, solomon h. snyder department of neuroscience and departments of psychiatry and behavioral sciences,the johns hopkins university school of medicine,baltimore,md, United States, department of microbiology,global health and emerging pathogens institute,department of medicine,division of infectious diseases,icahn school of medicine at mount sinai,ny,ny, United States, department of pharmacy and pharmacology,university of bath,claverton down,bath, United Kingdom, lady davis institute for medical research,jewish general hospital,montreal, Canada, inositol signaling group,laboratory of signal transduction,national institute of environmental health sciences,nih,dhhs,research triangle park,nc, United States, center for computational and integrative biology,massachusetts general hospital,harvard medical school,boston,ma, United States, program on emerging infectious diseases,duke-nus graduate medical school, Singapore
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|